Established in 2019, BioCentriq is a full-service, New Jersey-based CDMO for cell and gene therapy, focusing on all stages of process development and clinical manufacturing. With over 90 scientists, engineers, analysts, and manufacturing specialists, we have the quality systems and infrastructure required to support the release of both autologous and allogeneic drug products. BioCentriq also specializes in viral vector process development and manufacturing with expertise in a variety of cell and vector types.

Our 35,000 square feet of facilities includes four, soon to be five, ISO-7 certified GMP manufacturing suites, a fully equipped process development laboratory, quality control and analytical method development laboratories, and training facilities. We also operate the only McKinsey-owned Innovation & Learning Center designed to explore the application of industry 4.0, digital and lean manufacturing disciplines to life sciences.

Biotechnology

Life Sciences

BioCentriq

Shefali Shenai

Balázs Csóka

Sridevi Navuduri Viswanatha

Neeyav Shah

Kenneth de Avila

David Smith

Brendan Mooney

Chathuranga de Silva

Mary Loveras

Shannon Muldoon

Judit Hortobágyi

The Product Development team at BioCentriq is responsible for driving the creation and optimization of cell and gene therapy processes from concept to clinical manufacturing. They leverage scientific expertise and engineering solutions to ensure the effective transition of innovative therapies into scalable and compliant production strategies, while collaborating closely with quality control, engineering, and business development teams to meet industry standards and market demands. Through their efforts, the team plays a crucial role in advancing the company's mission of delivering high-quality therapeutic products to patients.

Product Development

Quality Control and Assurance

Product Development

About

Team members

Other teams at BioCentriq

Quality Control and Assurance